Multiple sclerosis cases in Germany
46.841 cases in the year 2018
46.079 cases in the year 2022 ( Prognosis )
The predicted increase in case numbers is based on population growth data from the Federal and State Statistical Offices. The calculation is made for each age group, so that demographic effects are taken into account. The case numbers are based on a network of different sources available to the public. By means of data analysis procedures, these figures are processed and made available to our users.
In most cases, a multiple sclerosis specialist is a qualified neurologist, whose focus is on diseases of the nervous system. However, since multiple sclerosis can potentially affect different regions of the body, a multiple sclerosis specialist will usually work with a multidisciplinary team of specialist doctors and healthcare professionals.
Which symptoms do multiple sclerosis specialists treat?
Some specific symptoms of multiple sclerosis may include:
- double vision
- blindness (in one eye)
- muscle weakness
- sensation difficulties
- coordination difficulties
Symptoms may disappear between attacks. However, permanent neurological problems may tend to persist, especially as the disease progresses.
What treatment methods are used by multiple sclerosis specialists?
Multiple sclerosis is not curable, and treatment typically aims to speed recovery from attacks, slow the progression of the disease and manage its symptoms. Some people with very mild symptoms will not need to resort to treatment.
Treatments for MS attacks
- corticosteroids are recommended to reduce inflammation of the nerves.
- plasmapheresis (blood plasma exchange) involves mixing blood cells with a protein solution.
Treatments to slow the advance of MS
MS can take two major forms:
- a continuously progressive type of MS
- a relapsing-remitting type of MS, with periods when symptoms may (temporarily) disappear
The immuno-suppressive drug ocrelizumab is the only recommended medication for slowing the advance of progressive forms of MS. For relapsing-remitting types of MS, there are several disease-modifying therapies available.
Treatment options for relapsing-remitting MS include:
- beta interferons, which are some of the most common medications prescribed for the treatment of MS. When injected underneath the skin or directly into a muscle, they can help to lower the frequency and severity of MS relapses.
- ocrelizumab is also approved for the relapse-remitting type of MS, because it has been shown to both cut the relapse rate of MS and slow the advance of disabling symptoms in the two main forms of the disease.
Other drugs that are used to slow the development of symptoms in relapsing-remitting MS include:
- glatiramer acetate
- dimethyl fumarate
Much of the immune system response associated with multiple sclerosis happens during the first phases of the disease. Early and aggressive medication treatments can reduce the relapse rate and slow down the formation of any new lesions.
Treatments for MS symptoms
- physiotherapy involves stretching and strengthening exercises to enhance daily functions.
- muscle relaxants may help to control painful muscle stiffness and spasms.
- medications may also help to minimise fatigue, as well as to combat other symptoms, such as pain, depression, and bowel or bladder control.
Many people with MS also use a number of alternative remedies to alleviate symptoms such as weakness and muscular pain. Activities such as acupuncture, exercise, massage, meditation, yoga, and relaxation techniques can play a part in increasing overall mental and physical wellbeing.
What additional qualifications are required by multiple sclerosis specialists?
A neurologist’s training includes four years of study at medical school, followed by one year basic clinical training and four years of residency (one year of internal medicine, then three years of neurology training). Some neurologists then undertake a two-year fellowship, during which they receive additional training focusing on their chosen specialist area of neurology. A multiple sclerosis fellowship is a recognised neurological subspecialty.